NeoGenomics, Inc. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
NeoGenomics, Inc. (NEO) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $118.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-13.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2018-03-13
- NeoGenomics, Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2015 was $118.00K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2015-12-31 | $118.00K 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |